Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2012
02/02/2012US20120029204 Synthesis of substituted-3-aminopyrazoles
02/02/2012US20120029202 Process for the Preparation of 5-Substituted 3-Aryl-3-(trifluoromethyl)-3,4-dihydro-2H-pyrroles
02/02/2012US20120029201 Process for the preparation of candesartan cilexetil
02/02/2012US20120029192 Pyrazole Derivatives
02/02/2012US20120029188 Substituted Aniline Derivatives
02/02/2012US20120029046 Crystalline form of sunitinib and processes for its preparation
02/02/2012US20120029011 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
02/02/2012US20120029004 Novel aminopyridine derivatives having aurora a selective inhibitory action
02/02/2012US20120029002 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases
02/02/2012US20120028997 Prokineticin 1 receptor antagonists
02/02/2012US20120028994 Compounds for the reduction of beta-amyloid production
02/02/2012US20120028990 3 aryl or heteroaryl-substituted indole derivative
02/02/2012US20120028989 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
02/02/2012US20120028983 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
02/02/2012US20120028978 Substituted bicyclic hcv inhibitors
02/02/2012US20120028963 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
02/02/2012US20120028962 Fused heterocyclic ring compound
02/02/2012US20120028961 6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist
02/02/2012US20120028959 Dihydroorotate dehydrogenase inhibitors
02/02/2012US20120028951 Pyridazinone compounds
02/02/2012US20120028907 Methods for identification of tumor phenotype and treatment
02/02/2012US20120028362 2-quinoxalinol salen compounds and uses thereof
02/02/2012US20120028291 Charged-balanced imaging agents
02/02/2012US20120028285 Clickable cross-linker
02/02/2012US20120028249 Anthraquinone based near ir emitting compounds and uses thereof
02/02/2012US20120027842 Topical formulations of flap inhibitors for administration to an eye
02/02/2012US20120027816 Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
02/02/2012US20120025183 Novel organic compound, light-emitting device, and image display apparatus
02/02/2012CA2809113A1 P2x4 receptor antagonist
02/02/2012CA2806701A1 Process for the synthesis of substituted urea compounds
02/02/2012CA2806610A1 Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k
02/02/2012CA2805078A1 Imidazole derivatives
02/02/2012CA2805043A1 Hetero-bicyclic derivatives as hcv inhibitors
02/02/2012CA2803689A1 Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms
02/02/2012CA2803387A1 Cyclic amine azaheterocyclic carboxamides
02/01/2012EP2411370A1 Compounds as cannabinoid receptor ligands
02/01/2012EP2411365A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
02/01/2012EP2411352A2 Antiviral compounds and uses thereof
02/01/2012EP2411010A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
02/01/2012EP2410844A1 Inhibitors of hepatitis c virus replication
02/01/2012EP2410841A1 Substituted bicyclic hcv inhibitors
02/01/2012EP2265601B1 Pyridazine derivatives as factor xia inhibitors
02/01/2012EP2066319B1 Benzotriazole kinase modulators
02/01/2012EP2049475B1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
02/01/2012EP1945629B1 Process for the preparation of candesartan cilexetil
02/01/2012CN102341390A Fluorine containing compounds and methods of use thereof
02/01/2012CN102341389A Fluorine containing compounds and methods of use thereof
02/01/2012CN102341388A Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
02/01/2012CN102341385A Piperazine compound capable of inhibiting prostaglandin d synthase
02/01/2012CN102341383A Inhibitors of Bruton's Tyrosine Kinase
02/01/2012CN102341376A 3-arylquinazolin-4-one compounds for combating invertebrate pests
02/01/2012CN102336745A 5-azobenzene and synthesis method thereof
02/01/2012CN102336744A Substituted triazoline ether ketone class compound and application thereof as bactericide as well as insecticide and acaricide
02/01/2012CN102336743A Triazoline ketone ether-substituted compound and application thereof
02/01/2012CN102336742A Substituted triazolinone ether compounds and application thereof
02/01/2012CN102336741A Fluorine-18-marked myocardial perfusion developing agent and preparation method and application thereof
02/01/2012CN102336716A 嘧啶衍生物 Pyrimidine derivatives
02/01/2012CN101528709B 对痕量胺相关受体有亲和性的氨基甲基-2-咪唑类 The trace amine associated receptors have affinity for the amino-methyl-2-imidazole
02/01/2012CN101522638B 哒嗪酮衍生物 Pyridazinones
01/2012
01/31/2012US8106197 Aminoheteroaryl compounds as protein kinase inhibitors
01/31/2012US8106193 Luminophores
01/31/2012US8106187 Process for the preparation of a macrocycle
01/31/2012US8106089 Reacting pyrrolylalkylcarbinole, furanylalkylcarbinole or thiophenylalkylcarbinole units; cyclodehydration, hydroboration, oxidation, palladium-catalyzed Suzuki-Miyaura cross-coupling; anticarcinogenic agents, antitumor, and antiproliferative agents; autoimmune and neurodegenerative diseases
01/31/2012US8106088 Fused bicyclic-substituted amines as histamine-3 receptor ligands
01/31/2012US8106086 Indoledione derivative
01/31/2012US8106063 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
01/31/2012US8106054 Crystalline pyridazine compound
01/31/2012US8106052 Luminescence-based methods and probes for measuring cytochrome P450 activity
01/31/2012US8106051 Utilities of amide compounds
01/31/2012US8106048 protozoal infestations in humans and animals, by bacteria, viruses or proteinaceous agents; neurological diseases or disorders; ischemia and/or reperfusion injury; 4-(4-Ethoxycarbonyl-4,5-dihydro-thiazol-2-yl)-piperidine-1-carboxylic acid t-butyl ester
01/31/2012CA2463989C Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
01/26/2012WO2012012612A2 Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes
01/26/2012WO2012011592A1 Heterocyclic compound and application thereof
01/26/2012WO2012011549A1 P2x4 receptor antagonist
01/26/2012WO2012011500A1 Azo pigment dispersion, ink composition using same, ink for inkjet recording, recording method, recorded material, and method for stabilizing ink for inkjet recording during storage
01/26/2012WO2012010826A1 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them
01/26/2012WO2012010534A1 Novel hetaryl (thio)carboxamide compounds for controlling invertebrate pests
01/26/2012WO2011109326A3 Crosslinking reagents, methods, and compositions for studying protein-protein interactions
01/26/2012US20120022270 Process for Preparing Dithiine-tetracarboxy-diimides
01/26/2012US20120022121 Indoles, derivatives and analogs thereof and uses therefor
01/26/2012US20120022119 Heterocyclic antagonists of prostaglandin d2 receptors
01/26/2012US20120022090 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
01/26/2012US20120022083 Small molecule modulators of cell adhesion
01/26/2012US20120022078 Aryl indole derivatives
01/26/2012US20120022074 Organic compounds
01/26/2012US20120022068 NOVEL HETEROCYCLIC NF-kB INHIBITORS
01/26/2012US20120022066 Insecticidal Triazines and Pyrimidines
01/26/2012US20120022064 Dihydroquinolinone derivatives
01/26/2012US20120022057 Bicyclic compounds as inhibitors of diacyglycerol acyltransferase
01/26/2012US20120022044 Triazole derivatives for treatment of alzheimer's disease
01/26/2012US20120020950 Antibacterial compounds
01/26/2012US20120020915 Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System
01/26/2012US20120018717 Organic electronic device, compounds for same, and terminal
01/26/2012CA2805567A1 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them
01/26/2012CA2804163A1 Novel hetaryl (thio)carboxamide compounds for controlling invertebrate pests
01/25/2012EP2409975A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same
01/25/2012EP2409969A1 Pyrimidine urea derivatives as kinase inhibitors
01/25/2012EP2409968A1 Crystals of non-natural-type stereoisomer salt of monatin and use thereof
01/25/2012EP2408766A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
01/25/2012EP2408763A2 Derivatives of n-ý(2-aza-bicycloý2.1.1¨hex-1-yl)-aryl-methyl¨-heterobenzamide, preparation thereof and application of same in therapeutics